<DOC>
	<DOCNO>NCT03087253</DOCNO>
	<brief_summary>Genetic lipodystrophy syndrome extremely rare , orphan disease overall estimate prevalence le 2,000 United States . These rare disorder characterize selective loss adipose tissue predisposition insulin resistance metabolic complication diabetes , dyslipidemia hepatic steatosis . Due metabolic problem , atherosclerotic vascular disease , recurrent episode acute pancreatitis , cirrhosis morbidity complicate live patient . In last year , several gene CGL ( AGPAT2 , BSCL2 , CAV1 PTRF ) ; FPL ( LMNA , PPARG , AKT2 , CIDEC , LIPE , PLIN1 , PCYT1A ADRA2A ) ; MAD ( LMNA ZMPSTE24 ) ; APS ( LMNA ) ; autoinflammatory ( PSMB8 ) ; NPS ( FBN1 , CAV1 ) ; SHORT syndrome ( PIK3R1 ) ; MDP syndrome ( POLD1 ) identify . However , paucity information natural history rare syndrome , especially genotype-specific cause morbidity mortality . To overcome problem outline , propose multicenter , collaborative , prospective , observational natural history cohort study patient genetic lipodystrophies . We propose follow approximately 500 patient genetic lipodystrophies yearly basis approximately 4 year collect robust clinical , metabolic , morbidity mortality data . Medical history patient questionnaire complete yearly basis patient register study . Clinical data vitals , laboratory result anthropometric measurement also collect patient ' medical record available .</brief_summary>
	<brief_title>The LD Lync Study - Natural History Study Genetic Lipodystrophy Syndromes</brief_title>
	<detailed_description />
	<mesh_term>Lipodystrophy</mesh_term>
	<criteria>Clinical diagnosis genetic lipodystrophy Supportive data : 1 ) Presence biallelic know diseasecausing variant gene autosomal recessive lipodystrophy syndrome ; 2 ) Presence know ( de novo loss function ) diseasecausing variant gene autosomal dominant lipodystrophy syndrome . HIVinfected patient lipodystrophies Autoimmune lipodystrophy Druginduced localize lipodystrophy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>